Statistics for The predicted risk of adverse pregnancy outcomes as a result of treatmentassociated obesity in a hypothetical population receiving tenofovir alafenamideemtricitabinedolutegravir tenofovir disoproxil fumarateemtricitabinedolutegravir or tenofovir diso